BioWaveGO RX— 510(k) K210202

Substantially Equivalent

Biowave Corporation

FDA 510(k) clearance K210202 for BioWaveGO RX, Substantially Equivalent on 2021-02-24. Applicant: Biowave Corporation.

Clearance details

Applicant
Biowave Corporation
Product code
Code GZJ
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Norwalk, CT, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.